Hydrea Package insert


  • Pill
  • Chronic myeloid leukemia
  • Resistant Head and neck cancer
  • Squamous cell
  • in combination with radiation therapy Malignant melanoma Ovarian carcinoma
  • Recurrent
  • metastatic
Back to: Full Site Navigation

FDA package inserts for Hydrea (Hydroxyurea)

This is the FDA package insert, supplied by pharmaceutical companies

Downloading FDA Package Insert for Hydrea capsule